MODIFICATION
65 -- Opportunistic Drugs and Home Base Care Drugs and Products Procurement
- Notice Date
- 8/18/2006
- Notice Type
- Modification
- NAICS
- 424210
— Drugs and Druggists' Sundries Merchant Wholesalers
- Contracting Office
- Department of Health and Human Services, Center for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, GA, 30341-4146
- ZIP Code
- 30341-4146
- Solicitation Number
- Reference-Number-07252006
- Response Due
- 8/29/2006
- Archive Date
- 9/13/2006
- Point of Contact
- John Ebanks, Contract Specialist, Phone 7704882436, Fax 7704882688, - Charlene Allison, Contract Specialist, Phone 770-488-2841, Fax 770-488-2688,
- E-Mail Address
-
JEbanks@cdc.gov, FKK1@cdc.gov
- Description
- NOTE: The Solicitation Number has changed to 200-2006-18431 * THIS RESPONSE IS DUE BY 10:00 AM ON 29 AUGUST 2006 * Department of Health and Human Services, Centers for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, GA, 30341-4146 The Centers for Disease Control and Prevention (CDC) is seeking potential offerors who have the capabilities of procuring Opportunistic Infection Drugs (OI) and Home Based Care Drugs & Products within and for Vietnam; this is a Request for Quotation for providing these services and products. The Government intends to award an Unpriced Firm Fixed-Price Purchase Order that will consist of a 6 month base period with four six month option period. The offerors will be required to undertake the product procurement through an open quotation system. The products are procured on open bid, with a minimum of three quotations required for each product. The product with the lowest cost, which can meet all of the specifications and quality requirement, is then procured. Included in this description is a sample list of OI Drugs that may be required to be purchased under the purchase order. Each offeror MUST submit ALL required certifications showing proof of meeting the government's requirements with their quotation, which are listed here: * Under Vietnam law and regulation only a registered and licensed pharmaceutical distributor may undertake physical distribution of pharmaceutical products. Additionally, PEPFAR Vietnam is currently operating in 40 provinces of Vietnam with a wide geographical range from the far Northern area to the far Southern area of the country; a longitudinal spread of around 2,000 Kms. The contractor must be able to operate over a wide geographical range. * The volume of medicines to be provided by PEPFAR, although small in comparison to the total country requirement, is nevertheless a significant proportion in relation to the central level public sector supply. Therefore the contractor must currently have high capacity volume capabilities and have adequate capacity to store and undertake the physical distribution volumes of medicines required by PEPFAR Vietnam. * Because a number of treatment sites have very low storage capacity for medicines, it is a requirement that the contractor store medicines and undertake frequent small deliveries to the treatment sites. Further, storage is required to hold emergency stocks and buffer stocks against possible unforeseen circumstances and erratic usage patterns. * It is a Ministry of Health (MoH) requirement, {Extraordinary Letter No. 6036/QLD-CL Ministry of Health, Drug Administration of Vietnam, Attention: Pharmaceutical Companies, enterprises attaining Good Practices (GPs)} that all new operations, must use only storage facilities that have ASEAN (Association of South-East Asian Nations) GSP (Good Storage Practice) certification. * It is a MoH and MoF requirement that all proposed medicine distribution must be approved in advance by both Ministries. * All offerors who are to procure, store and distribute medicines destined for use within the public sector of Vietnam must have within their possession/on file specific approval for each activity from both the MoH and MoF. * * Although the purchase order will be unpriced, all offerors are required to submit current pricing information for all drugs listed below. The requirement for current pricing information is for evaluation purposes. However, prices submitted will be used to determine the acceptability and fair and reasonability of prices included in resultant invoices. Those quotes that do not include pricing information will not be considered for award. Please refer to the attachment of sample drugs when developing price quotations. A price for each range listed shall be included. If quotations do not follow the format of the attachment and include prices for all quantity ranges, the quotation will not be considered. IAW FAR 13.302-2 a realistic monetary limitation shall be placed on the total order. The monetary limitation shall be an obligation subject to adjustment when the firm price is established. The contracting officer or the contracting officer?s designated representative shall review the invoice price and, if reasonable (see FAR13.106-3(a)), process the invoice for payment. The following Federal Acquisition Regulation (FAR) clauses are applicable to this combined synopsis/solicitation: 52.212-1 - Instructions to Offerors ? Commercial Items 52.212-3 ? Offeror Representations and Certifications ? Commercial Items 52.212-4 ? Contract Terms and Conditions ? Commercial Items 52.212-5 ? Contract Terms and Conditions Required to Implement Statutes or Executive Orders * * The Request for Quotations for this solicitation along with all proof of certification requirements MUST be emailed by electronic mail to egz2@cdc.gov (FIRST PREFERENCE) OR (IF YOU ARE NOT ABLE TO EMAIL) by mail delivered to: Centers for Disease Control and Prevention (CDC), mail Stop, K75 Attn: John Ebanks, Contract Specialist, 2920 Brandywine Rd, Atlanta, GA 30341-5539. Responses via facsimile (FAX) WILL NOT be accepted. Point of Contact John Ebanks, Contract Specialist, Phone 770-488-2436, Fax 770-488-2688, Email egz2@cdc.gov. Charlene Allison, Contract Specialist, Phone 770-488-2841, Fax 770-488-2688, Email FKK1@CDC.GOV. Andrea Roberson, Acquisition Logistics Specialist II, Phone 770-488-2687, Fax 770-488-2688, Email fpi1@cdc.gov. * ALL QUOTATIONS RECEIVED BY THIS OFFICE AFTER THE CLOSING DATE AND TIME SPECIFIED SHALL BE DETERMINED TO BE LATE AND WILL NOT BE CONSIDERED FOR AWARD * Sample List of Drugs: Cotrimoxazole, Cotrimoxazole syrup, Fluconazole, Fluconazole suspension, Itraconazole, Acyclovir, Acyclovir solution, Dapsone, Trimethoprim, Trimethoprim solution, Clindamycin, Primaquine, Azithromycin, Amphotericin B, Multivitamin, Multivitamin syrup, Acetaminophen, Acetominophen syrup, Acetominophen syrup, Ibuprofen, Ibuprofen suspension, Loperamide, Metaclopramide, Metaclopramide, Metaclopramide liquid, Prochlorperazine, Prochlorperazine liquid, Prochlorperazine, Permethrin 5%, Lindane 1%, Gatifloxacin, Doxycycline, Ceftriaxone IM, Penicillin Benzathine - IM, Penicillin Benzathine - IM, Penicillin Procaine - IV, Ganciclovir, Valganciclovir, Acetominophen/Codeine, Salbutamol Nebulizers, Prednisolone, Promethazine, Promethazine Syrup, Mebendazole, Albendazole Syrup, DEP 30mg (bottles), Aspirin 325mg, Simethicone 80mg, Vitamin B compound, Oral Rehydration Salts (sachet), Calamine Lotion (bottle), Petrolium Jelly, Alcohol (Liter), Zinc Oxyde Talcum Powder, Medicated Balm, Hydrogen Peroxide 3% (100ml), Povidine Iodine (liter), Condom, Ciprofloxacin, Ketoconazole, Nystatin solution, Spiramycin, Amoxicillin, Clarythromycin, Zinnat, Ofloxacin, Cephalexin, Metronidazole, Negram, Nalicid, Erythromycin, Bristopen, L-bio (sachet), Berberine, Nospa 40 mg, Phosphalugel, Boganic, Peritol 4mg, Smecta, Maalox, Sorbitol, Alaxan, Loratidine, Cimetidine, Biosubtyl, Lecithin, Diclofenac 50 mg (Arthritis), Terpin codeine, Acemuc, Cough lozenges, Stugeron 250mg, Antibiotic ointment, Corticosteroids cream, Nizoral cream, Acyclovir ointment, Acne skin cream, Ercefuril, vitamine A solution, Vitamine C, Iron Pills (Ferimax), Iron with folate pills (Fefolic), Chlorpheniramin 4mg, Pyrimethamine, Acetylcysteine
- Place of Performance
- Address: Address: Hanoi, ,
- Country: VIET NAM
- Country: VIET NAM
- Record
- SN01119187-W 20060820/060818220536 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |